The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques

AIMS: The activation of cannabinoid receptor type 2 (CB(2))-mediated pathways might represent a promising anti-atherosclerotic treatment. Here, we investigated the expression of the endocannabinoid system in human carotid plaques and the impact of CB(2) pharmacological activation on markers of plaqu...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Montecucco, Fabrizio, Di Marzo, Vincenzo, da Silva, Rafaela F., Vuilleumier, Nicolas, Capettini, Luciano, Lenglet, Sébastien, Pagano, Sabrina, Piscitelli, Fabiana, Quintao, Silvia, Bertolotto, Maria, Pelli, Graziano, Galan, Katia, Pilet, Lucie, Kuzmanovic, Kristina, Burger, Fabienne, Pane, Bianca, Spinella, Giovanni, Braunersreuther, Vincent, Gayet-Ageron, Angèle, Pende, Aldo, Viviani, Giorgio Luciano, Palombo, Domenico, Dallegri, Franco, Roux-Lombard, Pascale, Santos, Robson A.S., Stergiopulos, Nikos, Steffens, Sabine, Mach, François
פורמט: Artigo
שפה:Inglês
יצא לאור: Oxford University Press 2012
נושאים:
Fasttrack Clinical
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3345556/
https://ncbi.nlm.nih.gov/pubmed/22112961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/ehr449
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים